Table 1.
Organism (No. Tested) and Antimicrobial Agent | Concentration (mg/L) | |||
---|---|---|---|---|
Mode | MIC50 | MIC90 | Range | |
Enterobacterales (n = 197) | ||||
Alafosfalin | 2 | 2 | > 8 | ≤0.031–>8 |
Di-alanyl fosfalin | > 8 | 8 | > 8 | ≤ 0.031–> 8 |
β-Cl-Ala-β-Cl-Ala | > 8 | > 8 | > 8 | 2–> 8 |
Fosfomycin | 4 | 4 | > 32 | 0.125–> 32 |
E. coli (n = 53) | ||||
Alafosfalin | 0.063 | 0.125 | 0.25 | ≤ 0.031–2 |
Di-alanyl fosfalin | 0.25 | 0.5 | 2 | ≤ 0.031–> 8 |
β-Cl-Ala-β-Cl-Ala | 8 | 8 | > 8 | 2–> 8 |
Fosfomycin | 0.5 | 0.5 | 1 | 0.125–8 |
K. pneumoniae (n = 87) | ||||
Alafosfalin | 2 | 2 | > 8 | 0.25–> 8 |
Di-alanyl fosfalin | > 8 | > 8 | > 8 | 0.5–> 8 |
β-Cl-Ala-β-Cl-Ala | > 8 | > 8 | > 8 | 8–> 8 |
Fosfomycin | 4 | 8 | > 32 | 2–> 32 |
E. cloacae (n = 27) | ||||
Alafosfalin | 1 | 1 | 1 | 0.125–4 |
Di-alanyl fosfalin | 4 | > 8 | > 8 | 0.25–> 8 |
β-Cl-Ala-β-Cl-Ala | > 8 | > 8 | > 8 | 8–> 8 |
Fosfomycin | 16 | 16 | 32 | 4–> 32 |
CPE (n = 128) | ||||
Alafosfalin | 2 | 1 | 4 | ≤ 0.031–> 8 |
Di-alanyl fosfalin | > 8 | 8 | > 8 | 0.063–> 8 |
β-Cl-Ala-β-Cl-Ala | > 8 | > 8 | > 8 | 2–> 8 |
Fosfomycin | 16 | 4 | 32 | 0.125–> 32 |
ESBL (n = 47) | ||||
Alafosfalin | 2 | 2 | > 8 | ≤ 0.031–> 8 |
Di-alanyl fosfalin | > 8 | 8 | > 8 | ≤ 0.031–> 8 |
β-Cl-Ala-β-Cl-Ala | > 8 | > 8 | > 8 | 2–> 8 |
Fosfomycin | > 32 | 8 | > 32 | 0.125–> 32 |
AmpC (n = 22) | ||||
Alafosfalin | > 8 | 4 | > 8 | 0.063–> 8 |
Di-alanyl fosfalin | > 8 | > 8 | > 8 | 0.063–> 8 |
β-Cl-Ala-β-Cl-Ala | > 8 | > 8 | > 8 | 8–> 8 |
Fosfomycin | 32 | 8 | > 32 | 0.125–> 32 |
Abbreviations: MIC50: concentration of antimicrobial required to inhibit 50% of isolates. MIC90: concentration of antimicrobial required to inhibit 90% of isolates. CPE: carbapenemase-producing Enterobacterales; ESBL: Enterobacterales with extended spectrum β-lactamase; AmpC: Enterobacterales with acquired AmpC β-lactamase.